NCT05439850

Brief Summary

The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on ultrasound at 1-year postoperatively.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for phase_4

Timeline
39mo left

Started Aug 2022

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2022Jul 2029

First Submitted

Initial submission to the registry

June 18, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 16, 2022

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

5.9 years

First QC Date

June 18, 2022

Last Update Submit

February 24, 2026

Conditions

Keywords

Rotator Cuff TearBioinductiveArthroscopic Rotator Cuff RepairRotator Cuff Tear Arthropathy

Outcome Measures

Primary Outcomes (1)

  • Rotator cuff repair integrity

    absence of full- or partial-thickness defect as demonstrated on ultrasound at 1-year postoperatively.

    Preoperative to 1 year postoperative

Secondary Outcomes (7)

  • PROMs scores for upper extremity function

    Preoperative to 2 years postoperative

  • PROMs scores for depression

    Preoperative to 2 years postoperative

  • PROMs scores for upper extremity pain interference

    Preoperative to 2 years postoperative

  • Shoulder Range of Motion

    Preoperative to 2 years postoperative

  • Shoulder Strength

    Preoperative to 2 years postoperative

  • +2 more secondary outcomes

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Surgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.

Procedure: arthroscopic rotator cuff repairDiagnostic Test: Ultrasound Imaging

Study Group

EXPERIMENTAL

Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.

Procedure: arthroscopic rotator cuff repairBiological: Bioinductive implantDiagnostic Test: Ultrasound Imaging

Interventions

This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.

Control GroupStudy Group

A bioinductive implant that is designed to promote healing of the torn rotator cuff tendon after surgery.

Also known as: Bioinductive patch
Study Group
Ultrasound ImagingDIAGNOSTIC_TEST

An ultrasound will be performed on each patient one year postoperatively.

Control GroupStudy Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indicated and scheduled for arthroscopic rotator cuff repair.
  • Full-thickness medium (1-3 cm), large (3-5 cm), and massive (\>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
  • Chronic, degenerative rotator cuff tears.
  • Ability to read and understand English.
  • Age ≥18 years
  • Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy

You may not qualify if:

  • Patient scheduled for open or mini-open rotator cuff repair
  • Prior surgery of affected shoulder (except diagnostic arthroscopy)
  • Partial-thickness rotator cuff tears
  • Small (\<1 cm) rotator cuff tears
  • Rotator cuff tears involving the subscapularis tendon
  • Acute and traumatic rotator cuff tears
  • Active infection
  • Cancer
  • Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Health

Detroit, Michigan, 48202, United States

RECRUITING

MeSH Terms

Conditions

Rotator Cuff InjuriesRotator Cuff Tear Arthropathy

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon InjuriesChondrocalcinosisArthritisJoint DiseasesMusculoskeletal DiseasesCrystal Arthropathies

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Stephanie J Muh, MC

    Henry Ford Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Johnny Kasto, MD

CONTACT

Stephanie J Muh, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The study participant will not have knowledge of which treatment group he/she is randomized into for the duration of the study. Because the care provider/investigator will be required to implant the bioinductive patch, the physician will know into which treatment group each patient falls.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized into one of two groups. In the "control group," patients will receive the current surgical treatment for rotator cuff tears: debridement and repair. Patients in the "experimental group" will receive a bio-inductive patch following the same surgical treatment. Both groups of patients will participate in postoperative ultrasound imaging studies.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Service Chief, Principal Investigator

Study Record Dates

First Submitted

June 18, 2022

First Posted

June 30, 2022

Study Start

August 16, 2022

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2029

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

No IPD will be shared with other researchers.

Locations